53
Participants
Start Date
May 1, 2017
Primary Completion Date
July 30, 2018
Study Completion Date
July 30, 2018
Ferric carboymaltose
Ferric Carboxymaltose solution \[Ferinject® (FCM), Vifor Pharma (Glattbrugg, Switzerland)\]
Placebo (Normal saline)
Normal saline (0.9% weight/volume (w/v) NaCl)
Cardiac magnetic resonance
Cardiac magnetic resonance including T2\* and T1-mapping sequences
ERESA, Valencia
Fundación Investigación Hospital Clínico Universitario de Valencia. Instituto de Investigación Sanitaria INCLIVA., Valencia
Hospital General de Castellón, Castellon
Hospital de Manises, Manises
Hospital General de Valencia, Valencia
Hospital la Fe, Valencia
Fundación para la Investigación del Hospital Clínico de Valencia
OTHER